ArticleFrontiers in oncology2022

Case Report: A Durable Response to Camrelizumab and Apatinib Combination Therapy in a Heavily Treated Small Cell Carcinoma of the Ovary, Hypercalcemic Type.

Guiling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.